Anjiesi (688581): Revenue shows signs of recovery, with continued investment in R&D.

The company released its financial results announcement for 2025 and Q1 2026. In 2025, the company achieved a total operating revenue of 594 million yuan, representing a year-on-year decrease of 6.74%; net profit attributable to shareholders was 222 million yuan, marking a year-on-year decline of 24.43%.

Western SecuritiesMay 14 00:00

Anges (688581): Continued investment in cutting-edge technology directions, with a potential turnaround expected by 2026.

The company's performance is under pressure in 2025, but it is expected to reverse its difficulties in 2026. The 'Buy' rating is maintained. The company released its 2025 annual report and the first-quarter report for 2026. In 2025, the company achieved operating revenue of 594 million yuan.

Open Source SecuritiesApr 24 00:00

Anges reported revenue of 594 million yuan in 2025, with a net profit attributable to shareholders of 222 million yuan, representing a year-on-year decrease of 24.43%. Overseas income accounted for 57.75% of total revenue.

R&D investment increased by 28.18%, and the R&D expense ratio rose to 12.78%.

lanjinger.comApr 23 19:40

Anjiesi: Summary of Anjiesi\'s 2025 Annual Report

SZSIApr 23 00:00 · Announcements

Anjiesi: Anjiesi 2025 Annual Report

SZSIApr 23 00:00 · Announcements

Anjiesi: Anjiesi\'s First Quarter Report for 2026

SZSIApr 23 00:00 · Announcements